Literature DB >> 3434203

The high rate of prevalence of CT-detected basal ganglia calcification in neuropsychiatric (CNS) brucellosis.

A M Mousa1, S A Muhtaseb, R R Reddy, A Senthilselvan, D S Al-Mudallal, A A Marafie.   

Abstract

Of 65 cases presenting with neuropsychiatric manifestations of brucellosis (CNS-brucellosis), 9(13.8%) had CT-detected basal ganglia calcification (BGC). Of these, 5 had meningitis and 4 had psychiatric manifestations as presenting features. The diagnosis of brucellosis was made by the finding of consistent history and physical findings and the presence of significantly elevated antibody titres and/or positive culture in the blood and/or CSF. In all the cases, BGC was in the form of punctate hyperdense non-enhancing shadows with average density 44.5-58.4 and maximum density 49-64HU. The calcification was unilateral in 3 cases, bilateral and symmetrical in 4 and bilateral but asymmetrical in 2. None of the cases had other predisposing conditions to BGC and in one of the cases did specific anti-brucella treatment effect a detectable change in the BGC. The finding of CT-detected BGC in patients coming from areas endemic for brucellosis should alert physicians to the possibility of underlying brucellar infection.

Entities:  

Mesh:

Year:  1987        PMID: 3434203     DOI: 10.1111/j.1600-0404.1987.tb03601.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study.

Authors:  Hakan Erdem; Seniha Senbayrak; Kaan Meriç; Ayşe Batirel; Mustafa Kasım Karahocagil; Rodrigo Hasbun; Gonul Sengoz; Hasan Karsen; Selçuk Kaya; Ayşe Seza Inal; Abdullah Umut Pekok; Mustafa Kemal Celen; Secil Deniz; Mehmet Ulug; Tuna Demirdal; Mustafa Namiduru; Recep Tekin; Tumer Guven; Emine Parlak; Sibel Bolukcu; Meltem Avci; Oguz Reşat Sipahi; Derya Ozturk-Engin; Kadriye Yaşar; Filiz Pehlivanoglu; Emel Yilmaz; Selma Ates-Guler; Esmeray Mutlu-Yilmaz; Selma Tosun; Fatma Sirmatel; Elif Sahin-Horasan; Ayhan Akbulut; Nefise Oztoprak; Yasemin Cag; Ayten Kadanali; Huseyin Turgut; Ali Irfan Baran; Hanefi Cem Gul; Mahmut Sunnetcioglu; Asli Haykir-Solay; Affan Denk; Asuman Inan; Celal Ayaz; Asim Ulcay; Sukran Kose; Canan Agalar; Nazif Elaldi
Journal:  Infection       Date:  2016-05-02       Impact factor: 3.553

Review 2.  Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.

Authors:  Giulia Donzuso; Giovanni Mostile; Alessandra Nicoletti; Mario Zappia
Journal:  Neurol Sci       Date:  2019-07-02       Impact factor: 3.307

3.  Fahr Disease: A Rare Cause of First-Time Seizure in the Emergency Department.

Authors:  Faleh M Aldawsari; Turki B Alotaibi; Omran S Hashim; Zainab A Bu Hamad; Maha R Eisaa; Abdulrahman A Alhumaidi; Salem M Alanazi; Fahad F Alenezi; Afnan A Batwie; Abdulaziz A Habib; Sukainah S Alismail; Omar S Almulhim; Abdullah F Al Amer; Thamer A Alghamdi; Faisal Al-Hawaj
Journal:  Cureus       Date:  2021-11-28

Review 4.  Fahr's syndrome: literature review of current evidence.

Authors:  Shafaq Saleem; Hafiz Muhammad Aslam; Maheen Anwar; Shahzad Anwar; Maria Saleem; Anum Saleem; Muhammad Asim Khan Rehmani
Journal:  Orphanet J Rare Dis       Date:  2013-10-08       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.